HDAC2 and chronic obstructive pulmonary disease: In their study of a COPD animal model, they found that this may result from an increase in histone deacetylase-2 (HDAC2) activity (lower activity of HDAC2 is one of the potential causes for decreased effects of corticosteroid therapy) [55].